Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

2016107 citationsJournal Articlegreen Open Access

Authors

Carla Abdelnour · Fundació ACE

Inger van Steenoven · Amsterdam UMC Location VUmc

Elisabet Londos · Lund University

‪Frederic Blanc‬ · Centre National de la Recherche Scientifique

Bjørn Auestad · Stavanger University Hospital

Milica G. Kramberger · Ljubljana University Medical Centre

Henrik Zetterberg

Abstract

Reduced levels of CSF amyloid beta 1-42 were associated with more rapid cognitive decline in Lewy body dementia patients. Future prospective studies should include larger samples, centralized CSF analyses, longer follow-up, and biomarker-pathology correlation. © 2016 International Parkinson and Movement Disorder Society.

Topics & Keywords

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Parkinson's Disease Mechanisms and Treatments

Publication Details

Published in: Movement Disorders

Volume 31, Issue 8, pp. 1203-1208

DOI: 10.1002/mds.26668

Field-Weighted Citation Impact: 6.78

Command Palette

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

Authors

Abstract

Topics & Keywords

Publication Details